Overview

Same-day Antiretroviral Therapy With BIC/F/TAF

Status:
Recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
WHO had recommened rapid ART initiation, defined as starting ART within 7 days or on the same day after HIV diagnosis, to improve HIV care continuum. Prior studies revealed that point-of-care diagnostic methods for the detection of HIV RNA can accelerate linkage to care and reduce anxiety. By shortening the interval between infectious disease physician referral, time-lag between screening and confirmatory tests, with the use of the newly developed point-of-care immunochromatographic confirmatory test, initiating a safe and potent antiretroviral therapy, BIC/F/TAF, on the same day of HIV confirmation will be feasible to improve linkage to care and to shorten the interval between HIV diagnosis and viral suppression.
Phase:
N/A
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborators:
Changhua Christian Hospital
Chi Mei Medical Hospital
Chung Shan Medical University
Far Eastern Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Municipal Ta-Tung Hospital
Mackay Memorial Hospital
National Cheng-Kung University Hospital
Treatments:
Emtricitabine
Emtricitabine tenofovir alafenamide
Tenofovir